PM: decision on the application for modification of an agreed PIP
Decision date
Decision
P/0366/2022: EMA decision of 9 September 2022 on the acceptance of a modification of an agreed paediatric investigation plan for durvalumab (Imfinzi), (EMEA-002028-PIP01-16-M03)